First Apparent Seizure
Patient presents after possible first seizure
All Pathways
NeurologyDiagnostic
First Unprovoked Seizure Evaluation in Adults
First Unprovoked Seizure Evaluation in Adults: First Apparent Seizure → Was This a Seizure? → Not a Seizure.
Pathway Overview
16 steps
Algorithm Steps
16 total
01Start 02Decision Was This a Seizure?
Differentiate from mimics
- Syncope (most common mimic)
- Psychogenic non-epileptic seizure
- Migraine with aura
- Movement disorders
- Transient global amnesia
03Action Not a Seizure
Evaluate for alternative diagnosis
- Syncope workup if indicated
- Cardiac evaluation (ECG, holter)
- Psychiatric evaluation if PNES suspected
- No AED indicated
04Decision Provoked or Unprovoked?
Identify acute symptomatic causes
- Provoked: metabolic (Na, glucose, uremia)
- Provoked: acute CNS insult (<7 days)
- Provoked: drug/alcohol withdrawal
- Unprovoked: no acute precipitant
05Action Acute Symptomatic Seizure
Treat underlying cause
- Correct metabolic abnormality
- Treat CNS infection/injury
- Usually no long-term AED needed
- Risk of epilepsy lower than unprovoked
06Action Brain Imaging
MRI preferred over CT
- MRI with epilepsy protocol (preferred)
- CT if MRI unavailable or contraindicated
- Look for structural causes
- Tumors, vascular malformations, cortical dysplasia
07Action EEG
Standard or prolonged EEG
- Routine EEG within 24-48h if possible
- Yield higher if sleep deprived
- Epileptiform activity increases recurrence risk
- Normal EEG does not rule out epilepsy
08Decision Assess Recurrence Risk
High vs low risk features
- Overall recurrence: 21-45% in 2 years
- HIGH RISK: prior brain insult (Level A)
- HIGH RISK: EEG epileptiform (Level A)
- HIGH RISK: abnormal MRI (Level B)
- HIGH RISK: nocturnal seizure (Level B)
09Action High Recurrence Risk
Consider AED initiation
- Risk may be 50-90% in 2 years
- AED reduces recurrence by ~35%
- Shared decision-making essential
- Discuss driving, employment, safety
10Decision To Treat or Not?
Shared decision-making
- AED does NOT prevent epilepsy development
- AED reduces recurrence risk short-term
- Consider patient preferences, occupation
- Discuss side effects, teratogenicity
11Action Start AED
Select appropriate medication
- Levetiracetam (LEV) - broad spectrum, low interactions
- Lamotrigine (LTG) - good for focal, slow titration
- Valproate - avoid in women of childbearing potential
- Monotherapy at low effective dose
12Action Patient Counseling
Safety and lifestyle
- Driving restrictions (typically 3-12 months)
- Avoid heights, heavy machinery, swimming alone
- Alcohol and sleep deprivation as triggers
- When to seek emergency care
13Outcome Neurology Follow-up
Ongoing care plan
- Reassess in 1-3 months
- If second seizure: epilepsy diagnosis
- Long-term AED if recurrence
- Consider epilepsy specialist referral
14Action Observation
Watchful waiting approach
- Seizure precautions
- Driving restrictions (varies by state)
- Return for recurrence
- Follow up in 1-3 months
- Path rejoins step 12Shared downstream outcome
15Action Lower Recurrence Risk
Observation reasonable
- Normal EEG, normal MRI
- No prior CNS injury
- ~20-30% recurrence risk
- Can defer AED treatment
- Close follow-up
- Path rejoins step 10Shared downstream outcome
16Action Laboratory Studies
Rule out provoking factors
- Glucose, electrolytes (Na, Ca, Mg)
- Renal function, LFTs
- Toxicology screen
- Lumbar puncture if infection suspected
- Path rejoins step 08Shared downstream outcome
Guideline Source
Evidence-based guideline: Management of an unprovoked first seizure in adults - AAN/AES
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not apply to pediatric first seizures
- Provoked seizures require different workup
- Status epilepticus management covered separately
- Driving restrictions vary by jurisdiction
Contraindicated Populations
pediatric
Applicable Regions
USEUglobal
EU: ILAE recommendations generally concordant
US: AAN/AES 2015 guideline reaffirmed 2024
Version 1Next review: 2028-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the First Unprovoked Seizure Evaluation in Adults?
The First Unprovoked Seizure Evaluation in Adults is a diagnostic clinical algorithm for Neurology. It provides a structured decision tree to guide clinical decision-making, based on Evidence-based guideline: Management of an unprovoked first seizure in adults - AAN/AES.
What guideline is the First Unprovoked Seizure Evaluation in Adults based on?
This algorithm is based on Evidence-based guideline: Management of an unprovoked first seizure in adults - AAN/AES (DOI: 10.1212/WNL.0000000000001487).
What are the limitations of the First Unprovoked Seizure Evaluation in Adults?
Known limitations include: Does not apply to pediatric first seizures; Provoked seizures require different workup; Status epilepticus management covered separately; Driving restrictions vary by jurisdiction. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the First Unprovoked Seizure Evaluation in Adults appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free